{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:23:38Z","timestamp":1793157818171,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Special Clinical Research Project for Clinical Service Expenses of National High-level Hospitals","award":["No.2022-NHLHCRF-LX-02-0115"],"award-info":[{"award-number":["No.2022-NHLHCRF-LX-02-0115"]}]},{"name":"China-Japan Friendship Hospital Central High level Hospital Clinical Research Project","award":["2024-NHLHCRF-JBGS-ZN-02"],"award-info":[{"award-number":["2024-NHLHCRF-JBGS-ZN-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04184-4","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:24:38Z","timestamp":1768011878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The dual oncogenic and protective roles of hashimoto\u2019s thyroiditis in papillary thyroid carcinoma: a cohort-based meta-analysis"],"prefix":"10.1186","volume":"24","author":[{"given":"Xuejiao","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyuan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"issue":"3","key":"4184_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S2213-8587(20)30401-0","volume":"9","author":"S Vaccarella","year":"2021","unstructured":"Vaccarella S, Lortet-Tieulent J, Colombet M, Davies L, Stiller CA, Sch\u00fcz J, et al. IICC-3 contributors. Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes Endocrinol. 2021;9(3):144\u201352.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"4184_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4184_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s12105-010-0236-9","volume":"5","author":"RV Lloyd","year":"2011","unstructured":"Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol. 2011;5(1):51\u20136.","journal-title":"Head Neck Pathol"},{"issue":"13","key":"4184_CR4","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the united States, 1974\u20132013. JAMA. 2017;317(13):1338\u201348.","journal-title":"JAMA"},{"issue":"1","key":"4184_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid"},{"issue":"2","key":"4184_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/thy.2009.0311","volume":"20","author":"B Biondi","year":"2010","unstructured":"Biondi B, Cooper DS. Benefits of Thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid. 2010;20(2):135\u201346.","journal-title":"Thyroid"},{"issue":"2","key":"4184_CR7","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2015","unstructured":"Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14(2):174\u201380.","journal-title":"Autoimmun Rev"},{"issue":"4\u20135","key":"4184_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","volume":"13","author":"P Caturegli","year":"2014","unstructured":"Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4\u20135):391\u20137.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"4184_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1210\/js.2018-00427","volume":"3","author":"N Silva de Morais","year":"2019","unstructured":"Silva de Morais N, Stuart J, Guan H, Wang Z, Cibas ES, Frates MC, et al. The impact of Hashimoto thyroiditis on thyroid nodule cytology and risk of thyroid cancer. J Endocr Soc. 2019;3(4):791\u2013800.","journal-title":"J Endocr Soc"},{"issue":"5","key":"4184_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/cen.12194","volume":"79","author":"V Marotta","year":"2013","unstructured":"Marotta V, Guerra A, Zatelli MC, Uberti ED, Di Stasi V, Faggiano A, et al. BRAF mutation positive papillary thyroid carcinoma is less advanced when hashimoto\u2019s thyroiditis lymphocytic infiltration is present. Clin Endocrinol (Oxf). 2013;79(5):733\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"15","key":"4184_CR11","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008\u201312.","journal-title":"JAMA"},{"key":"4184_CR12","doi-asserted-by":"publisher","first-page":"204201882092101","DOI":"10.1177\/2042018820921019","volume":"11","author":"K Kim","year":"2020","unstructured":"Kim K, Kim JK, Lee CR, Kang SW, Lee J, Jeong JJ, et al. Comparison of long-term prognosis for differentiated thyroid cancer according to the 7th and 8th editions of the AJCC\/UICC TNM staging system. Ther Adv Endocrinol Metab. 2020;11:2042018820921019.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"8","key":"4184_CR13","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3109\/0284186X.2011.602109","volume":"50","author":"D Ahn","year":"2011","unstructured":"Ahn D, Heo SJ, Park JH, Kim JH, Sohn JH, Park JY, et al. Clinical relationship between hashimoto\u2019s thyroiditis and papillary thyroid cancer. Acta Oncol. 2011;50(8):1228\u201334.","journal-title":"Acta Oncol"},{"issue":"1","key":"4184_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4274\/BMJ.galenos.2024.2023.10-9","volume":"21","author":"C Akcura","year":"2025","unstructured":"Akcura C, Alkan S, G\u00fcney SC, \u00c7avdar GG, \u015eenol E, Tan A, et al. Clinicopathological reflections of hashimoto\u2019s thyroiditis and papillary thyroid carcinoma coexistence. Med J Bakirkoy. 2025;21(1):19\u201323.","journal-title":"Med J Bakirkoy"},{"issue":"4","key":"4184_CR15","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/hed.28031","volume":"47","author":"AI B\u00e1ez Berr\u00edos","year":"2025","unstructured":"B\u00e1ez Berr\u00edos AI, Monaghan M, Brandwein-Weber M, van Gerwen M. Investigating the association between hashimoto\u2019s thyroiditis and papillary thyroid cancer. Head Neck. 2025;47(4):1214\u201322.","journal-title":"Head Neck"},{"issue":"1","key":"4184_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12020-024-03973-3","volume":"87","author":"J Cao","year":"2025","unstructured":"Cao J, Sun Y, Liu Y, Xu Y, Li X, Zhang W, et al. The impact of hashimoto\u2019s thyroiditis on the clinical outcome of papillary thyroid cancer after radioactive iodine therapy: a propensity score matching study. Endocrine. 2025;87(1):178\u201387.","journal-title":"Endocrine"},{"issue":"3","key":"4184_CR17","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s12020-016-1185-1","volume":"55","author":"MS Carvalho","year":"2017","unstructured":"Carvalho MS, Rosario PW, Mour\u00e3o GF, Calsolari MR. Chronic lymphocytic thyroiditis does not influence the risk of recurrence in patients with papillary thyroid carcinoma and excellent response to initial therapy. Endocrine. 2017;55(3):954\u20138.","journal-title":"Endocrine"},{"issue":"4","key":"4184_CR18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.bjorl.2017.05.005","volume":"84","author":"MCS C\u00f4rtes","year":"2018","unstructured":"C\u00f4rtes MCS, Rosario PW, Mour\u00e3o GF, Calsolari MR. Influence of chronic lymphocytic thyroiditis on the risk of persistent and recurrent disease in patients with papillary thyroid carcinoma and elevated antithyroglobulin antibodies after initial therapy. Braz J Otorhinolaryngol. 2018;84(4):448\u201352.","journal-title":"Braz J Otorhinolaryngol"},{"issue":"6","key":"4184_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1055\/a-2065-0845","volume":"55","author":"AN Demir","year":"2023","unstructured":"Demir AN, Kara Z, Sulu C, Uysal S, Sahin S, Zulfaliyeva G, et al. Does the association of hashimoto\u2019s thyroiditis with differentiated thyroid cancer really have a protective role? Horm Metab Res. 2023;55(6):388\u201394.","journal-title":"Horm Metab Res"},{"issue":"3","key":"4184_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bjorl.2014.04.006","volume":"81","author":"FM Girardi","year":"2015","unstructured":"Girardi FM, Barra MB, Zettler CG. Papillary thyroid carcinoma: does the association with hashimoto\u2019s thyroiditis affect the clinicopathological characteristics of the disease? Braz J Otorhinolaryngol. 2015;81(3):283\u20137.","journal-title":"Braz J Otorhinolaryngol"},{"issue":"5","key":"4184_CR21","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s13304-021-01087-3","volume":"73","author":"S Hamouri","year":"2021","unstructured":"Hamouri S, Bakkar S, Aljaafreh A, Bani Hani M, Heis H, Qasaimeh G, et al. Implications of a background of hashimoto\u2019s thyroiditis on the current Conservative surgical trend towards papillary thyroid carcinoma. Updates Surg. 2021;73(5):1931\u20135.","journal-title":"Updates Surg"},{"issue":"3","key":"4184_CR22","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s13304-024-01854-y","volume":"76","author":"AT Harmantepe","year":"2024","unstructured":"Harmantepe AT, Ozdemir K, Bayhan Z, Kocer B. The underestimated impact of Hashimoto thyroiditis on thyroid papillary carcinoma. Updates Surg. 2024;76(3):1085\u20139.","journal-title":"Updates Surg"},{"issue":"4","key":"4184_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.surg.2023.12.023","volume":"175","author":"DB Heo","year":"2024","unstructured":"Heo DB, Won HR, Tae K, Kang YE, Jeon E, Ji YB, et al. Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: the MASTER study. Surgery. 2024;175(4):1049\u201354.","journal-title":"Surgery"},{"issue":"3","key":"4184_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s12022-011-9164-9","volume":"22","author":"BY Huang","year":"2011","unstructured":"23, Huang BY, Hseuh C, Chao TC, Lin KJ, Lin JD. Well-differentiated thyroid carcinoma with concomitant hashimoto\u2019s thyroiditis present with less aggressive clinical stage and low recurrence. Endocr Pathol. 2011;22(3):144\u20139.","journal-title":"Endocr Pathol"},{"issue":"17","key":"4184_CR25","doi-asserted-by":"publisher","first-page":"15525","DOI":"10.1007\/s00432-023-05332-7","volume":"149","author":"H Huang","year":"2023","unstructured":"Huang H, Xu S, Ni S, Liu W, Liu S. Hashimoto\u2019s thyroiditis is negatively associated with lymph node metastasis in PTMC. J Cancer Res Clin Oncol. 2023;149(17):15525\u201333.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"4184_CR26","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3346\/jkms.2012.27.8.883","volume":"27","author":"JS Jeong","year":"2012","unstructured":"Jeong JS, Kim HK, Lee CR, Park S, Park JH, Kang SW, et al. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome. J Korean Med Sci. 2012;27(8):883\u20139.","journal-title":"J Korean Med Sci"},{"issue":"3","key":"4184_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12022-010-9124-9","volume":"21","author":"HS Kim","year":"2010","unstructured":"Kim HS, Choi YJ, Yun JS. Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis. Endocr Pathol. 2010;21(3):149\u201353.","journal-title":"Endocr Pathol"},{"issue":"1","key":"4184_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/hed.23854","volume":"38","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Myong JP, Jee HG, Chai YJ, Choi JY, Min HS, et al. Combined effect of hashimoto\u2019s thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer. Head Neck. 2016;38(1):95\u2013101.","journal-title":"Head Neck"},{"issue":"1","key":"4184_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1530\/ERC-15-0408","volume":"23","author":"SK Kim","year":"2016","unstructured":"Kim SK, Woo JW, Lee JH, Park I, Choe JH, Kim JH, et al. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma. Endocr Relat Cancer. 2016;23(1):27\u201334.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"4184_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10147-014-0754-7","volume":"20","author":"HY Kwak","year":"2015","unstructured":"Kwak HY, Chae BJ, Eom YH, Hong YR, Seo JB, Lee SH, et al. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis? Int J Clin Oncol. 2015;20(3):463\u201373.","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"4184_CR31","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1308\/rcsann.2021.0224","volume":"104","author":"J Lau","year":"2022","unstructured":"Lau J, Lee J, Mahipal M, Yang SP, Tan WB, Yuan NK, et al. Hashimoto\u2019s thyroiditis on outcomes in papillary thyroid cancer revisited: experience from South East Asia. Ann R Coll Surg Engl. 2022;104(6):465\u201371.","journal-title":"Ann R Coll Surg Engl"},{"issue":"5","key":"4184_CR32","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s00268-019-05337-9","volume":"44","author":"I Lee","year":"2020","unstructured":"Lee I, Kim HK, Soh EY, Lee J. The association between chronic lymphocytic thyroiditis and the progress of papillary thyroid cancer. World J Surg. 2020;44(5):1506\u201313.","journal-title":"World J Surg"},{"key":"4184_CR33","doi-asserted-by":"publisher","first-page":"772071","DOI":"10.3389\/fendo.2021.772071","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Lv H, Zhang S, Shi B, Sun Y. The impact of coexistent hashimoto\u2019s thyroiditis on central compartment lymph node metastasis in papillary thyroid carcinoma. Front Endocrinol (Lausanne). 2021;12:772071.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4184_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12902-022-00945-4","volume":"22","author":"B Ma","year":"2022","unstructured":"Ma B, Chen X, Zhao Z, Yin X, Ji Q, Zhou Y, et al. Coexisting CLT in PTC is an independent predictor of tumor aggressiveness for patients aged under 55: a retrospective analysis of 635 patients. BMC Endocr Disord. 2022;22(1):55.","journal-title":"BMC Endocr Disord"},{"key":"4184_CR35","doi-asserted-by":"crossref","unstructured":"Ma C, Xu J, Zheng G, Liu L, Song X, Zheng H. Hashimoto\u2019s Thyroiditis Shows Sex- and Age-Dependent Inverse Associations with Papillary Thyroid Carcinoma Progression: A Propensity Score-Matched Analysis of 6963 Surgical Cases. Ann Surg Oncol. 2025.","DOI":"10.1245\/s10434-025-18229-1"},{"issue":"4","key":"4184_CR36","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/coa.12520","volume":"41","author":"HY Nam","year":"2016","unstructured":"Nam HY, Lee HY, Park GC. Impact of co-existent thyroiditis on clinical outcome in papillary thyroid carcinoma with high preoperative serum antithyroglobulin antibody: a retrospective cohort study. Clin Otolaryngol. 2016;41(4):358\u201364.","journal-title":"Clin Otolaryngol"},{"issue":"3","key":"4184_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/07435800.2014.977911","volume":"40","author":"JY Park","year":"2015","unstructured":"Park JY, Kim DW, Park HK, Ha TK, Jung SJ, Kim DH, et al. Comparison of T stage, N stage, multifocality, and bilaterality in papillary thyroid carcinoma patients according to the presence of coexisting lymphocytic thyroiditis. Endocr Res. 2015;40(3):151\u20135.","journal-title":"Endocr Res"},{"key":"4184_CR38","doi-asserted-by":"crossref","unstructured":"Parvathareddy SK, Siraj AK, Siraj N, Ahmed SO, Al-Sobhi SS, Al-Dayel F et al. Evaluating the Influence of Hashimoto\u2019s Thyroiditis on Clinico-Pathological Characteristics and Prognostic Outcomes of Middle Eastern Differentiated Thyroid Carcinoma. Int J Endocrinol. 2024; 2024:9929782.","DOI":"10.1155\/2024\/9929782"},{"issue":"3","key":"4184_CR39","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1177\/0194599812445727","volume":"147","author":"LM Paulson","year":"2012","unstructured":"Paulson LM, Shindo ML, Schuff KG. Role of chronic lymphocytic thyroiditis in central node metastasis of papillary thyroid carcinoma. Otolaryngol Head Neck Surg. 2012;147(3):444\u20139.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"12","key":"4184_CR40","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.eprac.2021.07.011","volume":"27","author":"D Sakiz","year":"2021","unstructured":"Sakiz D, Sencar ME, Calapkulu M, Ozturk Unsal I, Aktas L, Ucan B, et al. The effects of chronic lymphocytic thyroiditis on clinicopathologic factors in papillary thyroid cancer. Endocr Pract. 2021;27(12):1199\u2013204.","journal-title":"Endocr Pract"},{"issue":"1","key":"4184_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/cen.13475","volume":"88","author":"E Song","year":"2018","unstructured":"Song E, Jeon MJ, Park S, Kim M, Oh HS, Song DE, et al. Influence of coexistent hashimoto\u2019s thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2018;88(1):123\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"4184_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12902-021-00923-2","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang L, Chen J, Yuan X, Wang J, Sun L, Jiang J, et al. Lymph node metastasis of papillary thyroid carcinoma in the context of hashimoto\u2019s thyroiditis. BMC Endocr Disord. 2022;22(1):12.","journal-title":"BMC Endocr Disord"},{"key":"4184_CR43","doi-asserted-by":"publisher","first-page":"881024","DOI":"10.3389\/fonc.2022.881024","volume":"12","author":"W Wang","year":"2022","unstructured":"Wang W, Wen L, Chen S, Su X, Mao Z, Ding Y, et al. Preoperative thyroid peroxidase antibody predicts recurrence in papillary thyroid carcinoma: A consecutive study with 5,770 cases. Front Oncol. 2022;12:881024.","journal-title":"Front Oncol"},{"issue":"3","key":"4184_CR44","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ejso.2022.11.014","volume":"49","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zheng J, Hu X, Chang Q, Qiao Y, Yao X, et al. A retrospective study of papillary thyroid carcinoma: hashimoto\u2019s thyroiditis as a protective biomarker for lymph node metastasis. Eur J Surg Oncol. 2023;49(3):560\u20137.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"4184_CR45","doi-asserted-by":"publisher","first-page":"445","DOI":"10.29271\/jcpsp.2024.04.445","volume":"34","author":"M Xie","year":"2024","unstructured":"Xie M, Xu ZX, Dai M, Zhu YY. Correlation between the clinicopathological features of papillary thyroid carcinoma complicated with hashimoto\u2019s thyroiditis, BRAF V600E gene Mutation, and RET gene rearrangement. J Coll Physicians Surg Pak. 2024;34(4):445\u201350.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"7","key":"4184_CR46","doi-asserted-by":"publisher","first-page":"e2118526","DOI":"10.1001\/jamanetworkopen.2021.18526","volume":"4","author":"S Xu","year":"2021","unstructured":"Xu S, Huang H, Qian J, Liu Y, Huang Y, Wang X, et al. Prevalence of Hashimoto thyroiditis in adults with papillary thyroid cancer and its association with cancer recurrence and outcomes. JAMA Netw Open. 2021;4(7):e2118526.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"4184_CR47","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00405-011-1732-6","volume":"269","author":"YH Yoon","year":"2012","unstructured":"Yoon YH, Kim HJ, Lee JW, Kim JM, Koo BS. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol. 2012;269(3):1013\u20137.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"Suppl 1","key":"4184_CR48","first-page":"E1019","volume":"38","author":"RC Zeng","year":"2016","unstructured":"Zeng RC, Jin LP, Chen ED, Dong SY, Cai YF, Huang GL, et al. Potential relationship between hashimoto\u2019s thyroiditis and BRAF(V600E) mutation status in papillary thyroid cancer. Head Neck. 2016;38(Suppl 1):E1019\u20131025.","journal-title":"Head Neck"},{"issue":"1","key":"4184_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13000-025-01639-w","volume":"20","author":"W Zhang","year":"2025","unstructured":"Zhang W, Liu B. Exploration of risk factors for the occurrence and recurrence of papillary thyroid carcinoma with hashimoto\u2019s thyroiditis based on next-generation sequencing. Diagn Pathol. 2025;20(1):48.","journal-title":"Diagn Pathol"},{"issue":"6","key":"4184_CR50","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00432-014-1629-z","volume":"140","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Dai J, Wu T, Yang N, Yin Z. The study of the coexistence of hashimoto\u2019s thyroiditis with papillary thyroid carcinoma. J Cancer Res Clin Oncol. 2014;140(6):1021\u20136.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4184_CR51","doi-asserted-by":"publisher","first-page":"117955492412870","DOI":"10.1177\/11795549241287085","volume":"18","author":"K Zheng","year":"2024","unstructured":"Zheng K, Mao J. Comparison and analysis of clinical features of papillary thyroid cancer complicated with hashimoto\u2019s thyroiditis. Clin Med Insights Oncol. 2024;18:11795549241287085.","journal-title":"Clin Med Insights Oncol"},{"key":"4184_CR52","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.2147\/CMAR.S310773","volume":"13","author":"L Zhou","year":"2021","unstructured":"Zhou L, Chen G, Sheng L, Liu N, Zhang B, Zeng Q, et al. Influence factors for lymph node metastasis in papillary thyroid carcinoma: hashimoto\u2019s thyroiditis has a weak effect on central or lateral lymph node metastasis. Cancer Manag Res. 2021;13:3953\u201361.","journal-title":"Cancer Manag Res"},{"issue":"6","key":"4184_CR53","doi-asserted-by":"publisher","first-page":"e2674","DOI":"10.1097\/MD.0000000000002674","volume":"95","author":"F Zhu","year":"2016","unstructured":"Zhu F, Shen YB, Li FQ, Fang Y, Hu L, Wu YJ. The effects of Hashimoto thyroiditis on lymph node metastases in unifocal and multifocal papillary thyroid carcinoma: A retrospective Chinese cohort study. Med (Baltim). 2016;95(6):e2674.","journal-title":"Med (Baltim)"},{"issue":"2","key":"4184_CR54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/dc.2840110207","volume":"11","author":"C Poropatich","year":"1994","unstructured":"Poropatich C, Marcus D, Oertel YC. Hashimoto\u2019s thyroiditis: fine-needle aspirations of 50 asymptomatic cases. Diagn Cytopathol. 1994;11(2):141\u20135.","journal-title":"Diagn Cytopathol"},{"issue":"2","key":"4184_CR55","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s12020-021-02967-9","volume":"75","author":"L Zhao","year":"2022","unstructured":"Zhao L, Wu F, Zhou T, Lu K, Jiang K, Zhang Y, et al. Risk factors of skip lateral cervical lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Endocrine. 2022;75(2):351\u20139.","journal-title":"Endocrine"},{"issue":"6","key":"4184_CR56","doi-asserted-by":"publisher","first-page":"e0269995","DOI":"10.1371\/journal.pone.0269995","volume":"17","author":"Q Tang","year":"2022","unstructured":"Tang Q, Pan W, Peng L. Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis. PLoS ONE. 2022;17(6):e0269995.","journal-title":"PLoS ONE"},{"issue":"12","key":"4184_CR57","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.2741\/4705","volume":"23","author":"L Pagano","year":"2018","unstructured":"Pagano L, Mele C, Sama MT, Zavattaro M, Caputo M, De Marchi L, et al. Thyroid cancer phenotypes in relation to inflammation and autoimmunity. Front Biosci (Landmark Ed). 2018;23(12):2267\u201382.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"2","key":"4184_CR58","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1089\/thy.2012.0237","volume":"23","author":"X Li","year":"2013","unstructured":"Li X, Abdel-Mageed AB, Mondal D, Kandil E. The nuclear factor kappa-B signaling pathway as a therapeutic target against thyroid cancers. Thyroid. 2013;23(2):209\u201318.","journal-title":"Thyroid"},{"issue":"70","key":"4184_CR59","doi-asserted-by":"publisher","first-page":"115028","DOI":"10.18632\/oncotarget.22854","volume":"8","author":"H Liu","year":"2017","unstructured":"Liu H, Tian Q, Ai X, Qin Y, Cui Z, Li M, et al. Dihydroartemisinin attenuates autoimmune thyroiditis by inhibiting the CXCR3\/PI3K\/AKT\/NF-\u03baB signaling pathway. Oncotarget. 2017;8(70):115028\u201340.","journal-title":"Oncotarget"},{"issue":"9","key":"4184_CR60","first-page":"51","volume":"10","author":"E Avramidou","year":"2023","unstructured":"Avramidou E, Gkantaras A, Dermitzakis I, Sapalidis K, Manthou ME, Theotokis P. Histological alterations in hashimoto\u2019s disease: A case-series ultrastructural study. Med (Basel). 2023;10(9):51.","journal-title":"Med (Basel)"},{"issue":"1","key":"4184_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1756-6614-3-11","volume":"3","author":"A Staii","year":"2010","unstructured":"Staii A, Mirocha S, Todorova-Koteva K, Glinberg S, Jaume JC. Hashimoto thyroiditis is more frequent than expected when diagnosed by cytology which uncovers a pre-clinical state. Thyroid Res. 2010;3(1):11.","journal-title":"Thyroid Res"},{"key":"4184_CR62","doi-asserted-by":"publisher","first-page":"801925","DOI":"10.3389\/fendo.2022.801925","volume":"13","author":"J Xu","year":"2022","unstructured":"Xu J, Ding K, Mu L, Huang J, Ye F, Peng Y, et al. Hashimoto\u2019s thyroiditis: A Double-Edged sword in thyroid carcinoma. Front Endocrinol (Lausanne). 2022;13:801925.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"4184_CR63","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13044-021-00117-x","volume":"14","author":"P Abbasgholizadeh","year":"2021","unstructured":"Abbasgholizadeh P, Naseri A, Nasiri E, Sadra V. Is Hashimoto thyroiditis associated with increasing risk of thyroid malignancies? A systematic review and meta-analysis. Thyroid Res. 2021;14(1):26.","journal-title":"Thyroid Res"},{"issue":"1","key":"4184_CR64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/thy.2013.0367","volume":"24","author":"Y Ito","year":"2014","unstructured":"Ito Y, Miyauchi A, Kihara M, Higashiyama T, Kobayashi K, Miya A. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27\u201334.","journal-title":"Thyroid"},{"issue":"12","key":"4184_CR65","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1089\/thy.2018.0263","volume":"28","author":"HS Oh","year":"2018","unstructured":"Oh HS, Ha J, Kim HI, Kim TH, Kim WG, Lim DJ, et al. Active surveillance of low-risk papillary thyroid microcarcinoma: A multi-center cohort study in Korea. Thyroid. 2018;28(12):1587\u201394.","journal-title":"Thyroid"},{"issue":"6","key":"4184_CR66","doi-asserted-by":"publisher","first-page":"764","DOI":"10.4158\/EP.14.6.764","volume":"14","author":"RM Tuttle","year":"2008","unstructured":"Tuttle RM. Risk-adapted management of thyroid cancer. Endocr Pract. 2008;14(6):764\u201374.","journal-title":"Endocr Pract"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04184-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04184-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04184-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:03:40Z","timestamp":1770347020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-04184-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4184"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04184-4","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}